- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ibnsina Pharma Co (ISPH)
Ibnsina Pharma Co stock price live, this page displays EGX ISPH stock exchange data. View the ISPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ibnsina Pharma Co real time stock price chart below.
What Is the Ibnsina Pharma Co Stock Price Today?
The Ibnsina Pharma Co stock price today is 10.360.
What Is the Stock Symbol for Ibnsina Pharma Co?
The stock symbol for Ibnsina Pharma Co is "ISPH."
What Stock Exchange Does Ibnsina Pharma Co Trade On?
Ibnsina Pharma Co is listed and trades on the Egypt stock exchange.
Is Ibnsina Pharma Co a Good Stock to Buy?
Determining whether Ibnsina Pharma Co, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISPH quote. (ISIN: EGS512O1C012)
What Is the Ibnsina Pharma Co Stock Price Today?
The Ibnsina Pharma Co stock price today is 10.360.
What Is the Stock Symbol for Ibnsina Pharma Co?
The stock symbol for Ibnsina Pharma Co is "ISPH."
What Stock Exchange Does Ibnsina Pharma Co Trade On?
Ibnsina Pharma Co is listed and trades on the Egypt stock exchange.
Is Ibnsina Pharma Co a Good Stock to Buy?
Determining whether Ibnsina Pharma Co, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISPH quote. (ISIN: EGS512O1C012)
10.360
+0.090(+0.88%)
Closed·
Fair Value
An estimate of a Ibnsina Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.820
10.370
52 wk Range
9.020
16.930
ISPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Ibnsina Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.82010.370
52 wk Range
9.02016.930
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ISPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ibnsina Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
16.508
Upside
+59.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.508
(+59.34% Upside)
Earnings
Latest Release
Sep 02, 2026
EPS / Forecast
0.21 / --
Revenue / Forecast
20.99B / --
Compare ISPH to Peers and Sector
Metrics to compare | ISPH | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipISPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.0x | 14.4x | −0.2x | |
PEG Ratio | 0.32 | 0.41 | 0.00 | |
Price/Book | 3.3x | 2.8x | 2.6x | |
Price / LTM Sales | 0.1x | 1.5x | 2.8x | |
Upside (Analyst Target) | 59.3% | 27.4% | 60.9% | |
Fair Value Upside | Unlock | 16.3% | 9.5% | Unlock |
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistics services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as telesales and promotion services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ibnsina Pharma (ISPH) Stock Price Today?
The Ibnsina Pharma stock price today is 10.360 EGP.
What Stock Exchange Does Ibnsina Pharma Trade On?
Ibnsina Pharma is listed and trades on the Egypt Stock Exchange.
What Is the Stock Symbol for Ibnsina Pharma?
The stock symbol for Ibnsina Pharma is "ISPH."
What Is the Ibnsina Pharma Market Cap?
As of today, Ibnsina Pharma market cap is 10.440B EGP.
What Is Ibnsina Pharma's Earnings Per Share (TTM)?
The Ibnsina Pharma EPS (TTM) is 0.86.
When Is the Next Ibnsina Pharma Earnings Date?
Ibnsina Pharma will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is ISPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Ibnsina Pharma Stock Split?
Ibnsina Pharma has split 3 times.
How Many Employees Does Ibnsina Pharma Have?
Ibnsina Pharma has 5500 employees.
What is the current trading status of Ibnsina Pharma (ISPH)?
As of Nov 09, 2026, Ibnsina Pharma (ISPH) is trading at a price of 10.360 EGP, with a previous close of 10.360 EGP. The stock has fluctuated within a day range of 9.820 EGP to 10.370 EGP, while its 52-week range spans from 9.020 EGP to 16.930 EGP.
What Is Ibnsina Pharma (ISPH) Price Target According to Analysts?
The average 12-month price target for Ibnsina Pharma is 16.508 EGP, with a high estimate of 19.03 EGP and a low estimate of 14.5 EGP. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +59.34% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.